NASDAQ · RDGT

Ridgetech, Inc.

$1.23 -$0.02 (-1.60%) 1D After hours

Key Metrics

$1.12M
Market cap
0.11×
P/E · TTM
$119.97M
Revenue · TTM
$10.19M
Net income
EPS · TTM $1.74
Dividend yield
Free cash flow $16.39M
Beta · 1Y 0.47
EBITDA · TTM −$284.91K
Gross margin 3.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Mar 23 high, the share price fell 100%.

    Peak close $537.00 on Mar 23; trough close $1.23 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -100%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 27
    The stock moved -48.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27
  • Mar 24
    The stock moved -96.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.12M
Enterprise value
Shares outstanding898.9K
52-wk range$1.02 – $702.00
Avg volume · 20D721.5K
Net cash
Book value / share$5.09
ExchangeNASDAQ
About Ridgetech, Inc.
IPO dateOct 1, 2009
Employees61

Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E0.11
P/S0.01
P/FCF0.07
EV/EBITDA
EV/Sales
Graham №$14.12

Profitability

Gross 3.2%
Operating -0.8%
Net 8.5%
FCF 13.7%
ROE / ROIC 44.9% · -3.6%

Financial Health

Current ratio1.82
Quick ratio1.53
Debt / equity
Debt / EBITDA
Net cash
Working capital$25.62M

Cash Flow · TTM

Operating CF $16.55M
Capex −$155.36K
Free cash flow $16.39M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

1.0
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$14.12 vs $1.23
Trades below classic defensive value — Graham-cheap
Fundamentals through 2025-09-30 · computed by TickerWolf from SEC filings